[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370189-105":59,"doc-detail-370189-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-pan-cancer-analysis-and-functional-studies-reveal-slc2a6-as-a-ferroptosis-modulator-in-hepatocellular-carcinoma","Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma","","Soluble vector family member 6 (SLC2A6) is linked to cancer aggressiveness and poor outcomes, but its role in hepatocellular carcinoma (HCC) is not fully defined. This study integrates multiple databases to associate SLC2A6 expression with clinical stage, methylation, drug sensitivity, immune infiltration, and immune checkpoint regulation. Gene Ontology/KEGG analyses support involvement in cell-cycle, P53 signaling, and ferroptosis. In vitro and in vivo experiments show SLC2A6 knockout suppresses HCC proliferation, migration, and invasion, highlighting ferroptosis-dependent mechanisms.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-pan-cancer-analysis-and-functional-studies-reveal-slc2a6-as-a-ferroptosis-modulator-in-hepatocellular-carcinoma/370189/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-pan-cancer-analysis-and-functional-studies-reveal-slc2a6-as-a-ferroptosis-modulator-in-hepatocellular-carcinoma/370189.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was the relationship between SLC2A6 and hepatocellular carcinoma investigated?","Question",{"text":112,"@type":113},"The study used multiple databases to examine links between SLC2A6 expression and clinical stage, methylation, drug sensitivity, immune infiltration, and immune checkpoint regulation, followed by GO/KEGG enrichment analyses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did SLC2A6 knockout show in hepatocellular carcinoma models?",{"text":117,"@type":113},"In vitro and in vivo experiments demonstrated that SLC2A6 knockout significantly suppressed HCC cell proliferation, migration, and invasion.",{"name":119,"@type":110,"acceptedAnswer":120},"Which pathway connects SLC2A6 to the observed anti-tumor effects?",{"text":121,"@type":113},"The inhibition was closely tied to the ferroptosis pathway, and SLC2A6 was associated with biological processes including cell cycle and P53 signaling in LIHC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370189,1790925754,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nComprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma  \nGuohong Yan1,5,6,7, Hailian Huang2,5,6,7, Ziyan Lu1,5,6, Meifeng Chen1,5,6, Xiang Wang1, Pei Zhong1, Chongjiu Qin1,5,6, Shutian Mo1,5,6, Chuangye Han1, Xiaoling Luo2,3,4,5,6􀀍 & Xinping Ye1􀀍  \nSoluble vector family member 6 (SLC2A6) has been implicated in the aggressiveness and poor prognosis of various cancers, yet its specific role in hepatocellular carcinoma (HCC) remains to be fully elucidated. This study utilized multiple databases to investigate the relationship between SLC2A6 expression and clinical stage, methylation status, drug sensitivity, immune infiltration, and immune checkpoint regulation. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted. Furthermore, in vitro and in vivo experiments were performed to assess the impact ofSLC2A6 knockout on the proliferation, migration, invasion, and underlying mechanisms in hepatocellular carcinoma (LIHC) cells. SLC2A6 expression was significantly correlated with tumor prognosis, clinical stage, and methylation levels, and was found to influence immune cell infiltration and immune checkpoint gene expression. In LIHC, SLC2A6 was associated with key biological processes, including the cell cycle, P53 signaling, and ferroptosis. Knockdown of SLC2A6 markedly suppressed the proliferation, migration, and invasion of HCC cells, with this inhibition being closely tied to the ferroptosis pathway. SLC2A6 plays a pivotal role in the regulation of pan-cancer processes, particularly in tumor prognosis and immune-related mechanisms. In LIHC, it emerges as a potential prognostic biomarker and therapeutic target for the regulation offerroptosis, offering new insights for targeted cancer therapies.  \nKeywords SLC2A6, Pan-cancer, Hepatocellular carcinoma, Ferroptosis, Immunity  \nCancer is a significant challenge that poses a threat to human life and health. The incidence and mortality rates are escalating year by year, and it is anticipated that the global cancer burden will increase by 50% by 20401. With the continuous advancement of medicine and scientific research, an increasing number of treatment approaches and factors influencing cancer progression have been uncovered. Currently, surgery, radiotherapy, and chemotherapy are conventional treatments2–4. while targeted therapy, photodynamic therapy, and photothermal therapy are also being developed and applied5,6. Tumor immunotherapy has offered new hope for cancer treatment. Immune checkpoint inhibitors (ICIs), such as antagonists of PD1, PD-L1, CTLA4, and LAG-3, have been successfully utilized in the treatment of various cancers and have achieved remarkable efficacy7–9. Nevertheless, only a small proportion of cancer patients respond to immune therapy, and immunotherapy resistance exists in the majority of cancer types10–12. Due to the complexity of the mechanisms of Tumor Microenvironment (TME) formation and alteration, the identification of cancer prognostic genes and immune biomarkers associated with TME can assist in  \n1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.  \n2School of Basic Medical Sciences, Guangxi Medical University, Nanning, China. 3The Second Affiliated Hospital of Guangxi Medical University, Nanning, China. 4Department of Experimental Research, Cancer Hospital of Guangxi Medical University, Nanning, China. 5Key Laboratory of Early Prevention andTreatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China. 6Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning, China. 7Guohong Yan and Hailian Huang contributed equally to this work and share first authorship. 􀀍 email: [Luoxiaoling67@126.com](Luoxiaoling67@","cbCaicncicHpvaBX","https://ap.wps.com/l/cbCaicncicHpvaBX","pdf",6942501,"English","# Background\n## Cancer burden and immunotherapy challenges\n## SLC2 family and SLC2A6 in disease\n# Study Design and Analyses\n## Database-based correlations\n## GO and KEGG enrichment\n# Experimental Validation\n## In vitro and in vivo functional tests\n## Effects on proliferation, migration, and invasion\n# Mechanistic Insights\n## Immune infiltration and checkpoint regulation\n## Ferroptosis pathway and related signaling\n# Clinical Implications\n## Prognostic biomarker and therapeutic target","[{\"question\":\"How was the relationship between SLC2A6 and hepatocellular carcinoma investigated?\",\"answer\":\"The study used multiple databases to examine links between SLC2A6 expression and clinical stage, methylation, drug sensitivity, immune infiltration, and immune checkpoint regulation, followed by GO/KEGG enrichment analyses.\"},{\"question\":\"What did SLC2A6 knockout show in hepatocellular carcinoma models?\",\"answer\":\"In vitro and in vivo experiments demonstrated that SLC2A6 knockout significantly suppressed HCC cell proliferation, migration, and invasion.\"},{\"question\":\"Which pathway connects SLC2A6 to the observed anti-tumor effects?\",\"answer\":\"The inhibition was closely tied to the ferroptosis pathway, and SLC2A6 was associated with biological processes including cell cycle and P53 signaling in LIHC.\"}]","Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma | PDF",1790187233,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/689cd41fa42d63397cb897154f9bb7d2.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5566632c56efea70c4261dceff3454c.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2a3f8b5f10f8e29fefc3517bfb9e6ed.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df9880bafa2d23db0fb25898115e8622.webp",980,1287]